Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2026)

Akebia Therapeutics (AKBA) has 10 years of Asset Utilization Ratio data on file, last reported at 0.63 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 9.73% year-over-year to 0.63 in Q1 2026; TTM through Mar 2026 was 0.63, a 9.73% decrease from a year earlier, with the FY2025 full-year figure at 0.79, up 14.16% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.63, down from 0.64 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for AKBA reached as high as 0.85 in Q1 2023 and fell as low as 0.09 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.6 across 5 years, with a median of 0.7 in 2025.
• On a YoY basis, Asset Utilization Ratio climbed as much as 17086.31% in 2022 and fell as far as 133.31% in 2022.
• Year by year, Asset Utilization Ratio stood at 0.58 in 2022, then jumped by 41.48% to 0.82 in 2023, then slipped by 8.29% to 0.75 in 2024, then declined by 14.83% to 0.64 in 2025, then retreated by 1.39% to 0.63 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.63 in Q1 2026, 0.64 in Q4 2025, and 0.63 in Q3 2025.